Dokumendid - Think Tank - Euroopa Parlament

Uuring - Study on Rare Diseases - 18-06-2024

Mon, 17 Jun 2024 22:00:00 GMT

There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This document was provided by the Policy Department for Economic, Scientific and Quality of Life Policies at the request of the Committee on Public Health (SANT).

Allikas : © Euroopa Liit, 2024 - EP

Lühitutvustus - Living in the EU: Education and Health - 30-04-2019

Tue, 30 Apr 2019 14:22:07 GMT

The European Union complements national health and education policies, in particular those with a cross-border dimension. The main responsibility for health and education, however, lies with the governments of its Member States. This combination explains the spread in government expenditure on national welfare policies among the Member States, and in particular in individual direct payments for health. In terms of the gender gap in the area, women with tertiary education still suffer employment gaps. Moreover, national differences in the number of hospital beds available and people suffering from obesity, mainly concentrated among elderly people, also stand out.

Allikas : © Euroopa Liit, 2019 - EP

Lühitutvustus - European Union action on cancer - 21-10-2015

Wed, 21 Oct 2015 12:22:00 GMT

Cancer is a major public health concern in terms of disease burden and economic cost. Prevention and early detection are key. The European Union (EU) contributes to tackling cancer with awareness-raising, guidance, investment in research, as well as information and coordination.

Allikas : © Euroopa Liit, 2015 - EP

Uuring - Towards a Harmonised EU Assessment of the Added Therapeutic Value of Medicines - 08-06-2015

Mon, 08 Jun 2015 22:00:00 GMT

TThis study, produced for the ENVI Committee by Policy Department A, investigates the possibility of a harmonised EU approach concerning the assessment of the added therapeutic value (ATV) of medicinal products. It reviews the current EU legal and policy framework and looks at the state-of-play within all 28 Member States. In addition, it presents the results of an in-depth analysis on the use of ATV in six selected EU countries. The study closes with policy recommendations on how a possible European harmonisation of the ATV assessment might be taken forward within the current legal framework.

Allikas : © Euroopa Liit, 2015 - EP

Briefing - The European Year for Development: Health - 26-03-2015

Wed, 15 Apr 2015 22:00:00 GMT

Although enjoying the highest possible standard of health is a human right, millions of people suffer from preventable and curable diseases. The Millennium Development Goals strongly emphasised health, leading to increased investment in the health sector. Major progress has been made in reducing child and maternal mortality, and in combatting communicable diseases, but several regions will not meet the health targets. The Ebola outbreak has drawn attention to the need for international cooperation in health matters. �Ϸ��վ is very conscious of the lessons learnt from the Ebola crisis. The Sustainable Development Goals are likely to include new health considerations and to propose universal health coverage. Promoting and supporting equitable access to health care is a focus of EU development cooperation. EU aid in areas such as nutrition, water and sanitation and climate change also improves health. �Ϸ��վ considers health a fundamental right and has called for clear financial thresholds to ensure that sufficient EU aid goes to health and education.

Allikas : © Euroopa Liit, 2015 - EP

Briefing - Reducing air pollution - National emission ceilings for air pollutants - 23-03-2015

Sun, 22 Mar 2015 23:00:00 GMT

Despite significant progress in recent decades, air pollution levels in the European Union still have adverse impacts on the environment and on health. The European Commission estimates that health-related costs of air pollution in the EU range from 390 to 940 billion euros per year. The proposed directive, which would replace the current National Emission Ceilings Directive, sets binding national reduction objectives for six air pollutants (SO2, NOx, NMVOCs, NH3, PM2.5 and CH4) to be met by 2020 and 2030. It will also implement the Gothenburg Protocol as amended in 2012. The European Commission estimates that implementation costs would range from 2.2 to 3.3 billion euros per year. Stakeholders have been divided over the level of ambition of the proposed ceilings. Both EU advisory committees have issued opinions and some national parliaments have made comments on the proposal. The Council held an orientation debate in June 2014. The ENVI Committee is expected to consider the draft report in April 2015. A more recent edition of this document is available. Find it by searching by the document title at this address: http://www.europarl.europa.eu/thinktank/en/home.html

Allikas : © Euroopa Liit, 2015 - EP

Briefing - Older people in Europe: EU policies and programmes - 06-05-2014

Wed, 14 May 2014 22:00:00 GMT

Older people are assuming a greater importance in the European Union as both their numbers and their proportion of the population increase due to the ageing of the population. The European Union (EU) and its Member States have adopted a number of policies and programmes that affect older people directly or support them in various ways.

Allikas : © Euroopa Liit, 2014 - EP

Briefing - Tackling invasive alien species in Europe - 28-11-2013

Thu, 28 Nov 2013 23:00:00 GMT

Some non-native animals, plants and micro-organisms can pose a serious threat to European flora and fauna, disrupt fragile ecosystems and also transmit diseases to people, decimate crops and damage infrastructure. Environmentalists and politicians have called for action to address this ecological, economic and social threat. In September 2013, the European Commission proposed a harmonised approach. Under the proposal there would be a ban on the import, sale, growing, use or release of selected species in the EU.

Allikas : © Euroopa Liit, 2013 - EP

Uuring - Workshop Proceedings on "e-Health" - 15-11-2013

Tue, 03 Dec 2013 23:00:00 GMT

This report summarises the presentations and discussions at the Workshop on e-Health, held at the European �Ϸ��վ in Brussels, on Tuesday 24 September 2013. The workshop was held in view of the finalisation of the ENVI Committee’s Own Initiative Report on the e-Health Action Plan 2012-2020 – Innovative healthcare for the 21st century’, which will serve as a basis for the adoption of a European �Ϸ��վ resolution. The workshop was hosted by MEP Ms Pilar AYUSO (EPP, ES), Rapporteur of the ENVI Committee’s Own Initiative Report, and MEP Ms Jill EVANS (The Greens/EFA, UK), MEP Mr James NICHOLSON (ECR, UK), MEP Ms Antonyia PARVANOVA (ALDE, BG), and MEP Mr Claudiu C. TĂNĂSESCU (S&D, RO) who contributed to the Own Initiative Report as Shadow Rapporteurs.

Allikas : © Euroopa Liit, 2013 - EP

Briefing - Financing and providing long-term care: The challenge of an ageing population - 11-06-2013

Mon, 17 Jun 2013 22:00:00 GMT

As more people live longer, the demand for long-term care in Europe is expected to increase significantly. Paying for and providing quality care will be important challenges as the proportion of the population over 80 years old more than doubles in the EU over the next 50 years.

Allikas : © Euroopa Liit, 2013 - EP

Uuring - Food Safety and Public Health Situation in Ireland - 19-03-2013

Tue, 18 Jun 2013 06:46:54 GMT

This briefing note provides an overview of the public health situation in Ireland. It presents the health status of the population, reviews determinants of health and highlights the major burden of disease. It describes the health care system and looks at some of the current healthcare challenges, especially those related to financing healthcare during a recession. It also looks at the future and at some of the government’s proposals for a sustainable and equitable healthcare service to the people of Ireland.

Allikas : © Euroopa Liit, 2013 - EP

Uuring - Proceedings of the Workshop on "Health Economics" - 15-01-2013

Tue, 18 Jun 2013 06:47:14 GMT

This report summarises the presentations and discussions at the Workshop on "Health Economics", held at the European �Ϸ��վ in Brussels, on Wednesday 28 November 2012. The aim of the workshop was to exchange views on how to improve the efficiency and effectiveness of health systems. The workshop was hosted by MEP Alojz Peterle (SL, EPP) and MEP Glenis Willmott (UK, S&D), Co-chairs of the Health Working Group within the ENVI Committee.

Allikas : © Euroopa Liit, 2013 - EP

Briefing - Reducing smoking rates in the EU - 30-09-2011

Sun, 09 Oct 2011 22:00:00 GMT

Smoking is the largest preventable cause of death in the EU, creating both direct costs to healthcare systems and indirect costs due to productivity loss.

Allikas : © Euroopa Liit, 2011 - EP

Analüüs - The ECJ Case Law on Cross-Border Aspects of Health Services - 15-01-2007

Tue, 18 Jun 2013 06:55:29 GMT

Introduction The EU has only residual competences in the field of health, by virtue of Article 152 EC, (first introduced, with even more restrictive content, as Art. 129 of the Treaty of Maastricht). This limited legal basis has made possible the adoption of support programmes and the delimitation of the scope of competence of some EU bodies and agencies. [...]

Allikas : © Euroopa Liit, 2007 - EP

Uuring - The Impact of the European Court of Justice Case Law on National Systems for Cross-Border Health Service Provision - 15-01-2007

Tue, 18 Jun 2013 06:55:30 GMT

Executive summary Cross-border health care is an issue of growing importance in the European Union. This briefing note provides information on the structure of health care systems with respect to cross-border health care in selected Member States. It examines to what extent rulings from the European Court of Justice (ECJ) have caused Member States to make legislative or administrative changes, and the challenges that have been experienced in this regard. Although patient mobility has increased, the current volume of patient mobility seems to be relatively low (around 1% of overall public expenditure on healthcare). Cross-border challenges predominantly concern planned healthcare as opposed to other forms of care. For planned care, the key challenge is the nature of the authorisation procedures which remain in place as a way of protecting national systems. The terms and application of the authorisation scheme are the central subject matter for the ECJ judgments. [...]

Allikas : © Euroopa Liit, 2007 - EP

Uuring - Health Care Systems in the EU: A Comparative Study - 01-11-1998

Tue, 18 Jun 2013 06:56:50 GMT

This is a new study requested by the Committee on Environment, Consumer Protection and Public Health, which replaces the existing study carried out in 1992. The new study looks in greater depth at the way in which the health systems of all 15 Member States function.

Allikas : © Euroopa Liit, 1998 - EP